| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0003204> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0004626> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0009818> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0017203> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0019982> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0019994> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0034927> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0034928> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0036524> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0042645> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C1136254> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35168505_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'National Antimicrobial Utilisation Surveillance Program.\', \'Communicable Disease Control Branch, SA Health, Adelaide.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Connor_Erin> <https://research.tib.eu/covid-19/entity/Hillock_Nadine> <https://research.tib.eu/covid-19/entity/Rasiah_Kavita>
?:doi	<https://research.tib.eu/covid-19/entity/10.33321/cdi.2022.46.6>
?:doi	10.33321/cdi.2022.46.6
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Communicable diseases intelligence (2018)
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35168505>
?:pmid	<https://research.tib.eu/covid-19/entity/35168505>
?:pmid	35168505
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic, Australia, 2020.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35168505>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35168505>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all